Share
twitterlinkedinfacebook
Image 1 of 1
27_FEA_082611DA02.jpg
OXFORD, CT.-26 AUGUST 2011-082611DA02- Richard Kaminski, a retiree from Oxford, was part of a clinical trial for the drug Zelboraf which the FDA recently approved a groundbreaking new drug for the treatment of a specific, deadly form of melanoma. <br />
Darlene Douty Republican American